Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk
- PMID: 19496730
- DOI: 10.1086/597550
Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk
Abstract
Objective: We evaluated the usefulness of topical decolonization therapy for reducing the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection among MRSA-colonized inpatients.
Design: Retrospective cohort study.
Setting and intervention: Three hospitals with universal surveillance for MRSA; at their physician's discretion, colonized patients could be treated with a 5-day course of nasal mupirocin calcium 2%, twice daily, plus chlorhexidine gluconate 4% every second day.
Patients and methods: MRSA carriers were later retested for colonization (407 subjects; study 1) or followed up for development of MRSA infection (933 subjects; study 2). Multivariable methods were used to determine the impact of decolonization therapy on the risks of sustained colonization (in study 1) and MRSA infection (in study 2).
Results: Independent risk factors for sustained colonization included residence in a long-term care facility (odds ratio [OR], 1.8 [95% confidence interval [CI], 1.1-3.2]) and a pressure ulcer (OR, 2.3 [95% CI, 1.2-4.4]). Mupirocin at any dose decreased this risk, particularly during the 30-60-day period after therapy; mupirocin resistance increased this risk (OR, 4.1 [95% CI, 1.6-10.7]). Over a median follow-up duration of 269 days, 69 (7.4%) of 933 patients developed infection. Independent risk factors for infection were length of stay (hazard ratio [HR], 1.2 per 5 additional days [95% CI, 1.0-1.4]), chronic lung disease (HR, 1.7 [95% CI, 1.0-2.8]), and receipt of non-MRSA-active systemic antimicrobial agents (HR, 1.8 [95% CI, 1.1-3.1]). Receipt of mupirocin did not affect the risk of infection, although there was a trend toward delayed infection among patients receiving mupirocin (median time to infection, 50 vs 15.5 days; P=.06).
Conclusions: Mupirocin-based decolonization therapy temporarily reduced the risk of continued colonization but did not decrease the risk of subsequent infection.
Comment in
-
Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help?Infect Control Hosp Epidemiol. 2009 Jul;30(7):633-5. doi: 10.1086/599020. Infect Control Hosp Epidemiol. 2009. PMID: 19496651 No abstract available.
Similar articles
-
Agents for the decolonization of methicillin-resistant Staphylococcus aureus.Pharmacotherapy. 2009 Mar;29(3):263-80. doi: 10.1592/phco.29.3.263. Pharmacotherapy. 2009. PMID: 19249946 Review.
-
Risk factors for development of methicillin-resistant Staphylococcus aureus-positive clinical culture in nasal carriers after decolonization treatment.Am J Infect Control. 2014 Jul;42(7):e75-9. doi: 10.1016/j.ajic.2014.03.011. Epub 2014 May 22. Am J Infect Control. 2014. PMID: 24855930
-
Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers.Infect Control Hosp Epidemiol. 2008 Jun;29(6):510-6. doi: 10.1086/588201. Infect Control Hosp Epidemiol. 2008. PMID: 18510460
-
Emergence of community-associated methicillin-resistant Staphylococcus aureus strains in the neonatal intensive care unit: an infection prevention and patient safety challenge.Clin Microbiol Infect. 2016 Jul;22(7):645.e1-8. doi: 10.1016/j.cmi.2016.04.013. Epub 2016 Apr 25. Clin Microbiol Infect. 2016. PMID: 27126609 Free PMC article.
-
Pre-surgical Nasal Decolonization of Staphylococcus aureus: A Health Technology Assessment.Ont Health Technol Assess Ser. 2022 Aug 23;22(4):1-165. eCollection 2022. Ont Health Technol Assess Ser. 2022. PMID: 36160757 Free PMC article. Review.
Cited by
-
Methicillin-resistant staphylococcus aureus nosocomial infection has a distinct epidemiological position and acts as a marker for overall hospital-acquired infection trends.Sci Rep. 2022 Oct 11;12(1):17007. doi: 10.1038/s41598-022-21300-6. Sci Rep. 2022. PMID: 36220870 Free PMC article.
-
HOME2 Study: Household Versus Personalized Decolonization in Households of Children With Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infection-A Randomized Clinical Trial.Clin Infect Dis. 2021 Dec 6;73(11):e4568-e4577. doi: 10.1093/cid/ciaa752. Clin Infect Dis. 2021. PMID: 32521007 Free PMC article. Clinical Trial.
-
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.Nat Rev Microbiol. 2019 Apr;17(4):203-218. doi: 10.1038/s41579-018-0147-4. Nat Rev Microbiol. 2019. PMID: 30737488 Free PMC article. Review.
-
Wiping out MRSA: effect of introducing a universal disinfection wipe in a large UK teaching hospital.Antimicrob Resist Infect Control. 2018 Dec 19;7:155. doi: 10.1186/s13756-018-0445-7. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 30574298 Free PMC article.
-
Reduction in methicillin-resistant Staphylococcus aureus colonisation: impact of a screening and decolonisation programme.J Infect Prev. 2016 Nov;17(6):294-297. doi: 10.1177/1757177416661406. Epub 2016 Aug 4. J Infect Prev. 2016. PMID: 28989493 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical